Trial Profile
A Study to Evaluate the Efficacy and Safety of Combination of Erlotinib and Temozolomide with Radiation in Elderly Non Small Cell Lung Cancer Patients with Brain Metastases
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Erlotinib (Primary) ; Temozolomide (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 15 Dec 2015 New trial record